跳至主要内容
临床试验/NCT01655394
NCT01655394Unknown不适用

Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

University of Cologne1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Clinical Improvement

研究概览

简要总结

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored.

详细描述

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • immune neuropathy
  • age above 18 y
  • IVIg treatment
  • no IVIg treatment

排除标准

  • 未提供

结局指标

主要结局

Clinical Improvement

时间窗: 6 Months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Helmar Lehmann

PD Dr. med. H. Lehmann

University of Cologne

研究点 (1)

Loading locations...

相似试验

Change of Nerve Conduction Properties in IVIg... | 临床试验